Ovarian function suppression
Ovarian function suppression has been studied in 5 papers since 2024: 3 observational studies in people, 2 reviews; 4 in the past year. The newest paper, Nov 20, 2026: “Estrogen loss and Alzheimer’s disease: five exposures ordered by age, and why timing is the variable to test”.
5 papers study it1 findingUpdated
4 new papers in 30 daysSee all 5 papers on ovarian function suppression
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“the tamoxifen plus OFS group had lower baseline MRS scores but higher scores at 6 and 12 months”
- 1 lab in 1 country
- Funders: Kangwon National University and 2 more
- Humans3
What is ovarian function suppression linked with?
1Studies link ovarian function suppression with menopausal symptom burden.
Menopausal symptom burden
upin humans1
1 study
Menopausal symptom burden
upin humans1
Ovarian function suppression is associated with menopausal symptom burden in humans (Estimate 6.084; standard error 1.306; P < .001).
HumansPremenopausal patients with breast cancer taking tamoxifen; comparison with tamoxifen alone6 monthsn = 209